ArticleInternational journal of preventive medicine2013
The Direct Medical Costs of Breast Cancer in Iran: Analyzing the Patient's Level Data from a Cancer Specific Hospital in Isfahan.
Article in International journal of preventive medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Economic burden of five common cancers in Iran: a systematic review of cost-of-illness with a focus on healthcare resource utilization.BMC health services research · 2025Pooled it
- Pooled it
- Cost analysis of female breast cancer in Antigua and Barbuda: a prevalence based study.Frontiers in public health · 2026Article
- National and Subnational Burden of Female Breast Cancer in Iran from 2010 to 2021.Diseases (Basel, Switzerland) · 2025Article
- A Scoping Review of 20 Years Breast Cancer Screening Programs in Iran.Iranian journal of public health · 2025Review
- Factors affecting the economic burden of breast cancer in southern Iran.BMC health services research · 2023Article
- Economic burden of breast cancer: a case of Southern Iran.Cost effectiveness and resource allocation : C/E · 2023Article
- Cost-Effectiveness of Breast Cancer Screening in Shiraz, Iran.International journal of preventive medicine · 2022Article
- Menstrual and Reproductive Factors and Risk of Breast Cancer in Iranian Female Population: A Systematic Review and Meta-Analysis.International journal of preventive medicine · 2022Review
- Economic Evaluations of Breast Cancer Care in Low- and Middle-Income Countries: A Scoping Review.The oncologist · 2021Article
- The Economic Burden Associated with the Management of Different Stages of Breast Cancer: A Retrospective Cost of Illness Analysis in Saudi Arabia.Healthcare (Basel, Switzerland) · 2021Article
- Incidence of household catastrophic and impoverishing health expenditures among patients with Breast Cancer in Iran.BMC health services research · 2021Article
- Cost analysis of breast cancer: a comparison between private and public hospitals in Iran.BMC health services research · 2021Article
- The Economic Burden of Cancer in Iran during 1995-2019: A Systematic Review.Iranian journal of public health · 2021Review
- Experiences of End-of-Life Care of Older Adults with Cancer From the Perspective of Stakeholdersin Iran: A Content Analysis Study.Asian Pacific journal of cancer prevention : APJCP · 2021Article
- National and Subnational Incidence, Mortality, and Years of Life Lost Due to Breast Cancer in Iran: Trends and Age-Period-Cohort Analysis Since 1990.Frontiers in oncology · 2021Article
- Use of data-mining to support real-world cost analyses: An example using HER2-positive breast cancer in Iran.PloS one · 2018Article
- Effect of health-belief-model-based training on performance of women in breast self-examination.Electronic physician · 2017Article
- The global burden of women's cancers: a grand challenge in global health.Lancet (London, England) · 2017Review
- Comparison of hematological parameters, iron levels, and oxidative stress in women with and without breast cancer: A case- control study.Medical journal of the Islamic Republic of Iran · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBreast cancer is one of the main causes of mortality and morbidity world-wide. The estimation of the direct medical costs of breast cancer can help payers of the cost to understand the burden of breast cancer on their limited financial resources as well as the society.
methodsWe used a cross-sectional study to calculate the direct medical costs of breast cancer among women in Isfahan, Iran. The medical records of all patients which were registered in Seyed Al-Shohada Hospital between March 2005 and March 2010 were reviewed. The relevant data from patients' profiles extracted. The direct medical costs of received services were calculated with both public and private tariffs.
resultsThe total numbers of 467 patients in various disease stages were included into the study. The average age of patients was 49 years. The average direct cost per patient per month in stages I to IV were 222.17, 224.61, 316.51 and 828.52 US$, respectively. The surgery cost was the main cost driver for stages I and II with private tariffs. However for stages III and IV, the medication cost was the main cost component for managing breast cancer.
conclusionsThe direct economic cost of breast cancer in Iran is very high; nonetheless, as the age of breast cancer in Iran is nearly 10 years lower than Western countries, the burden of the disease in Iran is expected to be significantly high. Medication therapy is the main cost component of the breast cancer.
Indexed as
Identifiers
24049592PMC3775213What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.